Navigation Links
Epilepsy Drug Shows Improvement in Parkinson Disease Patients

Researchers Miho Murata and colleagues with the National Center of Neurology and Psychiatry in Tokyo have observed //a significant decrease in symptoms of Parkinson disease patients with use of a different drug.

The finding published in January 2, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology, was observed when patients not responding to the usual prescribed drug levodopa, were given varied doses of zonisamide, a drug used in the treatment of epilepsy.

"Zonisamide treatment improved all main Parkinson disease symptoms in these patients, including tremor and other disabling dyskinesias”, claims Murata.

Source-Eurekalert
'"/>




Page: 1

Related medicine news :

1. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Epilepsy can be predicted
4. Epilepsy Drugs Can Enhance Risk of Birth Defects
5. Epilepsy Drug Helps Diabetic Nerve Damage
6. Epilepsy Drug May Relieve Chronic Headaches
7. More Complications Seen In Women With Epilepsy
8. Epilepsy Drugs Found To Lead To Bone Loss
9. Another Use For Epilepsy Drugs
10. Epilepsy Patients Could Benefit From Pacemakers
11. Early Surgery For Treatment Of Epilepsy Questioned
Post Your Comments:
(Date:12/2/2008)...atistics for sexual assault are unsettling; the De...ge women will be the victim of attempted or actual...ew study, researchers from two universities, inclu...ollege women often are unaware of drug-facilitated...certain behaviors, including leaving drinks unatte...
(Date:12/2/2008)...y, December 2, 2008 at 3 pm CST)--Radiology and ca...ty of South Carolina in Charleston, S.C., today pr...exposure to radiation during computed tomography f...that new estimates are several times lower than pr...ers presented their findings at the annual meetin...
(Date:12/2/2008)...uries accounted for 3.5 percent of high school ath...e first study to examine rare injuries and conditi...clude eye injuries, dental injuries, neck and cerv...ich may result in high morbidity, costly surgeries... Football was associated with the highest rate of ...
(Date:12/2/2008)...e/ -- Breast-Specific Gamma Imaging (BSGI) has,be...ue for the diagnosis of,invasive lobular carcinom...GI,is a molecular breast imaging technique that c...discover very early stage cancers. When compared t...imaging (MRI), BSGI has the,greatest sensitivity ...
Breaking Medicine News(10 mins):Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2
...ty Medical Center reveal a surprising new origin f...apparatus -- a stack of pancake-shaped compartmen...ular destinations -- is the source of a particular... Scientists have long thought that microtubules, ...
...ancer treatment comes in the form of Intraoperativ... of radiation during surgery . Thus the patient ca...the Princess Margaret Hospital team combined the e...cine specialists (radiation oncologists, physicist...
... Wednesday toward offering vaccinations against ce... that could be carried out by late next year. The...JCVI) recommended the use of vaccines to guard aga... transmitted infection which causes most cases of ...
...ersity School of Medicine in St. Louis have just g...ealing that smoking interferes with ligament heal...model and found that cigarette smoking impairs the...ite and delays healing following ligament repair s...
Other Medicine News:Health News:Research in the Origin of Microtubules 2Health News:Research in the Origin of Microtubules 3Health News:Intraoperative Radiation Therapy a New Step in Breast Cancer Treatment 2Health News:Girls Could Be Vaccinated Against Cervical Cancer in Britain 2Health News:Smoking Hampers Healing of the Ligament 2
(Date:12/2/2008)...e/ -- TorreyPines Therapeutics, Inc. (Nasdaq: TP...tient Phase II trial evaluating three doses of NGX...n patients with Sjogren,s syndrome. NGX267 met th...increase in salivary flow production compared to p.... These doses were safe and well tolerated with fe...
(Date:12/1/2008)...FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: ...of the world,s leading medical journals, results o..., experimental compound tasimelteon (VEC-162). Th...Melatonin agonist tasimelteon (VEC-162) for transi...d controlled multicentre trials." Results are repo...
(Date:12/1/2008)... is a two-way switch that, if turned off, causes l...hat they lose their identity and become more like ... Dec. 1 Scientists at ...red that a certain differentiated cell type is so ...constant expression of a gene called Prox1 to di...
(Date:12/1/2008)...ll/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOV...ing,human vaccines for diseases caused by HIV-1 (...s agents, announced today that the launch of its P...welve sites across North and South America.,These...tional Institutes of,Health (NIH), and the HIV Va...
Breaking Medicine Technology:TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 2TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 3TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 4TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia 5Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Biochemists manipulate fruit flavor enzymes 4553 1Biochemists manipulate fruit flavor enzymes 4553 2Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 25636 1Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 25636 2Medicare Advantage Plans Struggle to Comply With New Federal Law 25633 1Medicare Advantage Plans Struggle to Comply With New Federal Law 25633 2Longs Drug Stores Corporation Reports Second Quarter Results 25630 1Longs Drug Stores Corporation Reports Second Quarter Results 25630 2Longs Drug Stores Corporation Reports Second Quarter Results 25630 3Longs Drug Stores Corporation Reports Second Quarter Results 25630 4Longs Drug Stores Corporation Reports Second Quarter Results 25630 5Longs Drug Stores Corporation Reports Second Quarter Results 25630 6Longs Drug Stores Corporation Reports Second Quarter Results 25630 7Longs Drug Stores Corporation Reports Second Quarter Results 25630 8Longs Drug Stores Corporation Reports Second Quarter Results 25630 9Longs Drug Stores Corporation Reports Second Quarter Results 25630 10Longs Drug Stores Corporation Reports Second Quarter Results 25630 11Longs Drug Stores Corporation Reports Second Quarter Results 25630 12Longs Drug Stores Corporation Reports Second Quarter Results 25630 13
...NESS WIRE)--May 31, 2007 - Hemispherx Biopharma, I...ed in the clinical,development and manufacture of ...nounced today a new scientific report featuring,it...LDO in,combating highly pathogenic avian influenza...a low-dose experimental oral formulation,of the Co...
...ta from XL880, Phase II data from XL999 studies,sc...ons -, SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswi...at data from clinical trials of,the company,s inve...ented at the 2007 American Society of Clinical Onc...une 1 to 5 in Chicago,Illinois. , , -- Data fr...
Other Medicine Technology:Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 2Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 3Hemispherx Presents Potential Avian Influenza Treatment,Breakthrough at Paris Conference 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters.
...technology developed over Guidants 20-year history...new foundation for successful treatment outcomes. ...with a lower profile shaft,more flexible markers, ...ross tight and tortuous anatomy with even greater ...
...nt AFP IRMA,is an immunoradiometric assay design...etoprotein (AFP) in serum. It is,intended strict..., (a) serial measurements to aid in the,manageme...ancer and,other conditions associated with abnor...
Medicine Products: